Cardlytics Inc CEO Karim Temsamani Sells 31,123 Shares
On January 3, 2024, CEO Karim Temsamani sold 31,123 shares of Cardlytics Inc (NASDAQ:CDLX), as reported in a recent SEC filing. The transaction was executed with the shares priced at $7.77, resulting in a total sale amount of approximately $241,785.71.
Cardlytics Inc operates in the advertising and marketing industry, providing a platform that allows financial institutions to run reward programs that promote customer loyalty and provide marketers with insights based on purchase data. The company's technology integrates with banking digital channels to enable marketers to reach consumers through personalized offers.
Over the past year, the insider has sold a total of 292,659 shares and has not made any purchases of the company's stock. The recent sale by the insider is part of a trend observed over the past year, where there have been no insider buys and 10 insider sells for Cardlytics Inc.
Shares of Cardlytics Inc were trading at $7.77 on the day of the insider's sale, giving the company a market capitalization of $305.986 million.
The stock's price-to-GF-Value ratio stands at 0.25, with a GuruFocus Value of $31.70 for Cardlytics Inc. This valuation suggests that the stock is currently categorized as a Possible Value Trap, and potential investors may want to think twice before making an investment decision.
The GF Value is determined by considering historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's historical returns and growth, and future business performance estimates provided by Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
